UBS Group
CRNC icon

UBS Group’s Cerence CRNC Stock Holding History

UBS Group’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$930K Buy
82,127
+2,733
+3% +$26.8K ﹤0.01% 5797
2026
Q1 		$501K Sell
79,394
-61,988
-44% -$558K ﹤0.01% 6085
2025
Q4 		$1.51M Sell
141,382
-45,256
-24% -$497K ﹤0.01% 5214
2025
Q3 		$2.33M Buy
186,638
+96,922
+108% +$993K ﹤0.01% 4811
2025
Q2 		$916K Sell
89,716
-333,009
-79% -$2.93M ﹤0.01% 5524
2025
Q1 		$3.34M Buy
422,725
+278,111
+192% +$3.42M ﹤0.01% 4211
2024
Q4 		$1.14M Buy
144,614
+21,653
+18% +$109K ﹤0.01% 5204
2024
Q3 		$387K Buy
122,961
+12,264
+11% +$36.1K ﹤0.01% 5412
2024
Q2 		$313K Buy
110,697
+54,646
+97% +$389K ﹤0.01% 5361
2024
Q1 		$883K Sell
56,051
-1,986
-3% -$33.6K ﹤0.01% 4698
2023
Q4 		$1.14M Buy
58,037
+19,796
+52% +$344K ﹤0.01% 4374
2023
Q3 		$779K Sell
38,241
-5,176
-12% -$130K ﹤0.01% 4302
2023
Q2 		$1.27M Buy
43,417
+24,733
+132% +$678K ﹤0.01% 4006
2023
Q1 		$525K Buy
18,684
+8,077
+76% +$207K ﹤0.01% 4645
2022
Q4 		$197K Sell
10,607
-703
-6% -$12K ﹤0.01% 5468
2022
Q3 		$179K Buy
11,310
+4,145
+58% +$93.1K ﹤0.01% 5190
2022
Q2 		$181K Sell
7,165
-7,713
-52% -$231K ﹤0.01% 5006
2022
Q1 		$537K Sell
14,878
-31,932
-68% -$1.57M ﹤0.01% 4634
2021
Q4 		$3.59M Buy
46,810
+11,506
+33% +$1.01M ﹤0.01% 3194
2021
Q3 		$3.39M Sell
35,304
-2,144
-6% -$234K ﹤0.01% 3097
2021
Q2 		$4M Buy
37,448
+9,714
+35% +$956K ﹤0.01% 2918
2021
Q1 		$2.48M Buy
27,734
+5,682
+26% +$625K ﹤0.01% 3340
2020
Q4 		$2.21M Sell
22,052
-3,576
-14% -$267K ﹤0.01% 3321
2020
Q3 		$1.25M Sell
25,628
-10,943
-30% -$525K ﹤0.01% 3477
2020
Q2 		$1.49M Buy
36,571
+28,897
+377% +$830K ﹤0.01% 3152
2020
Q1 		$118K Sell
7,674
-601
-7% -$12.6K ﹤0.01% 5139
2019
Q4 		$187K Buy
+8,275
New +$136K ﹤0.01% 5648

Other funds holding CRNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
ACM
American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $310M AUM 45.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

UBS Group's CRNC Position: Q2 2026 in Review

UBS Group increased its Cerence (CRNC) stake by 3.4% in Q2 2026, buying an estimated $26.8K and bringing the position to 82,127 shares worth $930K. The position accounts for ﹤0.01% of the portfolio, ranked #5797.

UBS Group first reported a position in CRNC in Q4 2019 and has held it in 27 quarters since. The position peaked at $4M in Q2 2021. 196 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • UBS Group held 82,127 shares of Cerence worth $930K as of Q2 2026.
  • UBS Group bought 2,733 Cerence shares in Q2 2026, an estimated $26.8K.
  • Cerence made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5797 holding.
  • UBS Group first reported a position in Cerence in Q4 2019 and has held it in 27 quarters since.
  • UBS Group's Cerence position peaked at $4M in Q2 2021.
  • 196 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.